ELI LILLY & Co is 88.5x more valuable than IONIS PHARMACEUTICALS INC by market capitalization ($1.072 T vs $12.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IONS | LLY |
|---|---|---|
| Market cap | $12.12 B | $1.072 T |
| US-listed rank | #835 | #10 |
| Revenue (latest FY) | $943.71M | $65.18B |
| Net income (latest FY) | -$381.39M | $20.64B |
| Net margin | -40.4% | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 2,623 | 989 |
ELI LILLY & Co is 88.5x more valuable than IONIS PHARMACEUTICALS INC by market capitalization ($1.072 T vs $12.12 B).
In their latest fiscal years, IONIS PHARMACEUTICALS INC reported $943.71M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: IONIS PHARMACEUTICALS INC and ELI LILLY & Co, or browse the full rankings.